Matthew Hughes, MD
Colon & Rectal Surgery · Plano, TXNPI 1013111889
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Pfizer at 34.9% of the total. 2025 is the largest year on record at $1,335, 4.7 times the $285 reported in 2019. That places this record below the midpoint for colon & rectal surgery clinicians in TX, where the typical reported total is $4,072.
Across 31 payments — averaging $97.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$1K
- THD America, Inc.$884
- Intuitive Surgical$443
- Medtronic$124
- Heron Therapeutics, Inc.$117
- Johnson & Johnson$87
- plus $317 from 11 others
What the payments were for
- Speaking & faculty fees$1,00033%
- Travel & lodging$56819%
- Food & beverage$1,45848%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 2 | $1,056 |
| THD America, Inc. | 5 | $884 |
| Intuitive Surgical | 6 | $443 |
| Medtronic | 1 | $124 |
| Heron Therapeutics, Inc. | 1 | $117 |
| Johnson & Johnson | 1 | $87 |
| Integra Lifesciences Corporation | 3 | $54 |
| AbbVie | 2 | $48 |
| Conmed Corporation | 1 | $45 |
| TELA Bio, Inc. | 2 | $42 |
| Shire North American Group Inc | 1 | $24 |
| Next Science LLC | 1 | $23 |
| Acera Surgical, Inc. | 1 | $20 |
| Vertex | 1 | $18 |
| Baudax Bio Inc. | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $14 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BRAFTOVI$1,000
- Da Vinci Surgical System$234
- LigaSure$124
- Zynrelef$117
How this compares
$3,026 in reported general payments places this provider in the 40th percentile of 200 colon & rectal surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin Sulfate | 16 | $89 |
| Tramadol Hcl | 18 | $65 |
| Metronidazole | 18 | $40 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Plano
- Thiru LakshmanAustin$756K
- Diego Marines CopadoHouston$462K
- Bidhan DasSugar Land$350K
- Christopher de JesusSan Antonio$201K
- Farshid AraghizadehFort Worth$181K
- Jefferson HurleyIrving$163K
- Erik AskenasyHouston$142K
- Eric HaasHouston$140K
- Robert JacobsonDallas$125K
- Theodoros VoloyiannisHouston$100K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.